KENYA CALLS FOR STRONGER GLOBAL DRUG CONTROL MEASURES AT 68TH CND IN VIENNA

Kenya’s stance at the CND aligns with global efforts to strengthen drug control frameworks and protect public health.

Kenya Who Drugs control Cnd Health risk.
Member of Parliament Dido Raso, representing Kenya
Member of Parliament Dido Raso, representing Kenya
Kenya has reiterated its commitment to strengthening global drug control measures, urging international bodies to enhance surveillance and evaluation of emerging substances posing public health risks. 

Speaking at the 68th Commission on Narcotic Drugs (CND) in Vienna, Saku Member of Parliament Dido Raso, representing Kenya, called for greater international collaboration in addressing the misuse of pharmaceuticals and veterinary drugs.

Raso emphasized the urgent need for a global response to the rising abuse of substances such as Tramadol, Ketamine, and Xylazine, which have increasingly been misused both in Kenya and worldwide. 

He urged the World Health Organization (WHO) and the International Narcotics Control Board (INCB) to intensify research and regulatory efforts to curb the growing threat of these substances.

“Kenya appreciates and honors the treaty-mandated role of the World Health Organization (WHO) and the International Narcotics Control Board (INCB) in identifying and conducting research on substances whilst evaluating their impact on human health.” Raso stated.

Highlighting the growing misuse of pharmaceuticals, the MP called for further scrutiny of Tramadol and a review of Ketamine, both of which have seen rising abuse rates. “While I have the floor, I wish to urge the WHO once again to consider undertaking further evaluation of Tramadol and continue discussions leading to consideration of Ketamine, whose use and misuse are on the rise,” he noted.

Raso also raised alarm over the use of veterinary drugs, such as Xylazine, in illicit drug mixtures, a practice that has led to severe health consequences. He stressed the need for urgent intervention, stating, “We have further witnessed the increased use of veterinary medicines such as Xylazine in making drug mixtures. We call on WHO for further review and advice on control measures,” 

Kenya’s stance at the CND aligns with global efforts to strengthen drug control frameworks and protect public health. By advocating for a science-driven and collaborative approach, Kenya aims to contribute to international strategies that effectively combat the evolving challenges of substance abuse.

As discussions continue at the 68th CND, Kenya remains firm in its position, calling for stronger international regulatory mechanisms to prevent the harmful effects of emerging substances on communities worldwide.

Comments

You must be logged in to comment.